Pharmaceutical company outreach to healthcare professionals (HCPs) in the time of COVID-19 is fraught with challenges. Not all HCPs are currently on the frontlines of the fight against COVID-19. These HCPs, like many of us, are struggling to maintain some semblance of normalcy in a world full ofOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.